Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 41

Trial Status

Completed3
Other5

Role Distribution

Principal Investigator4
Other Roles4
PI Rate50%

Activity Timeline

Clinical Trials (8)

NCT04724148Not ApplicableUnknown
Impact of Fentanyl Analgesia on the Accuracy of HVPG Measurements in Patients With Portal Hypertension
Liver CirrhosisPainPortal Hypertension
StudychairStart date: 2022-01-01
NCT04883177Completed
Effectiveness and Safety of the COVID-19 Vaccination for Patients With Liver Disease (CHESS2101)
COVID-19Liver DiseaseVaccine Reaction
StudychairStart date: 2021-05-11
NCT04028323Phase 4Unknown
Functional MRI-based Assessment of Terlipressin vs. Octreotide on Renal Function in Cirrhotic Patients With Acute Variceal Bleeding (CHESS1903)
Acute Variceal BleedingRenal Function Disorder
PrincipalinvestigatorStart date: 2019-07-16

Research Network

Collaboration Network

41 collaborators·83 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Ye Gu, MD

Shenyang Sixth People's Hospital

Moderately Similar
2 trials

Shared therapeutic areas:

Compensated Advanced Chronic Liver DiseaseCOVID-19Liver Cirrhosis+1 more

Worked with same sponsors:

Affiliated Hospital of Jiangsu UniversityAnkang Central Hospital+15 more
Collaborated on 2 trials
Similarity Score48%

Fengmei Wang, MD

Tianjin Second People's Hospital

Moderately Similar
2 trials

Shared therapeutic areas:

Compensated Advanced Chronic Liver DiseaseCOVID-19Liver Cirrhosis+1 more

Worked with same sponsors:

Affiliated Hospital of Jiangsu UniversityAnkang Central Hospital+15 more
Collaborated on 2 trials
Similarity Score48%

Guo Zhang, MD

Guangxi Zhuang Autonomous Region

Moderately Similar
2 trials

Shared therapeutic areas:

Compensated Advanced Chronic Liver DiseaseCOVID-19Liver Cirrhosis+1 more

Worked with same sponsors:

Affiliated Hospital of Jiangsu UniversityAnkang Central Hospital+15 more
Collaborated on 2 trials
Similarity Score48%

Chuxiao Shao, MD

The Central Hospital of Lishui City

Moderately Similar
2 trials

Shared therapeutic areas:

Compensated Advanced Chronic Liver DiseaseCOVID-19Liver Cirrhosis+1 more

Worked with same sponsors:

Affiliated Hospital of Jiangsu UniversityAnkang Central Hospital+15 more
Collaborated on 2 trials
Similarity Score48%

Xujun Yang, master

LanZhou University

Moderately Similar
1 trials

Shared therapeutic areas:

Liver CirrhosisPainHypertension, Portal

Worked with same sponsors:

Hepatopancreatobiliary Surgery Institute of Gansu ProvinceLanZhou University+3 more
Collaborated on 1 trial
Similarity Score34%

Chuan guang Wang, Master

The Fifth Affiliated Hospital of Wenzhou Medical University & Lishui Central Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Liver CirrhosisPainHypertension, Portal

Worked with same sponsors:

Hepatopancreatobiliary Surgery Institute of Gansu ProvinceLanZhou University+3 more
Collaborated on 1 trial
Similarity Score34%

Fangyu Xu

LanZhou University

Moderately Similar
1 trials

Shared therapeutic areas:

Liver CirrhosisPainHypertension, Portal

Worked with same sponsors:

Hepatopancreatobiliary Surgery Institute of Gansu ProvinceLanZhou University+3 more
Collaborated on 1 trial
Similarity Score34%

Weizhong Zhou, MD

The First Affiliated Hospital with Nanjing Medical University

Moderately Similar
1 trials

Shared therapeutic areas:

Liver CirrhosisPainHypertension, Portal

Worked with same sponsors:

Hepatopancreatobiliary Surgery Institute of Gansu ProvinceLanZhou University+3 more
Collaborated on 1 trial
Similarity Score34%

Wenhong Zhang, MD

Huashan Hospital

Moderately Similar
4 trials

Shared therapeutic areas:

COVID-19Liver DiseasesVaccine Reaction

Worked with same sponsors:

Affiliated Hospital of Yunnan UniversityBaoding People's Hospital+37 more
Collaborated on 1 trial
Similarity Score34%

YuJiang Yin

LanZhou University

Moderately Similar
1 trials

Shared therapeutic areas:

Liver CirrhosisPainHypertension, Portal

Worked with same sponsors:

Hepatopancreatobiliary Surgery Institute of Gansu ProvinceLanZhou University+3 more
Collaborated on 1 trial
Similarity Score34%

Publications (0)

No publications found for this investigator.

Clinical Trials (8)

Showing 8 of 8 trials

NCT04724148Not ApplicableStudyChair

Impact of Fentanyl Analgesia on the Accuracy of HVPG Measurements in Patients With Portal Hypertension

Liver CirrhosisPainPortal Hypertension
Unknown
NCT05140837PrincipalInvestigator

Early Diagnosis and Timely Treatment of Cirrhotic Patients With Minimal Hepatic Encephalopathy (CHESS-NCRCID 2106)

CirrhosisHepatic Encephalopathy
Unknown
NCT04883177StudyChair

Effectiveness and Safety of the COVID-19 Vaccination for Patients With Liver Disease (CHESS2101)

COVID-19Liver DiseaseVaccine Reaction
Completed
NCT04546360StudyChair

Spleen Stiffness Combined With Liver Stiffness Measured by 2D-SWE for the Screening of High-risk Varices in Compensated Advanced Chronic Liver Disease (CHESS2004)

Compensated Advanced Chronic Liver DiseaseVariceal Hemorrhage
Completed
NCT04329559StudyChair

COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study

COVID-19Liver Cirrhosis
Completed
NCT04028323Phase 4PrincipalInvestigator

Functional MRI-based Assessment of Terlipressin vs. Octreotide on Renal Function in Cirrhotic Patients With Acute Variceal Bleeding (CHESS1903)

Acute Variceal BleedingRenal Function Disorder
Unknown
NCT03990753PrincipalInvestigator

Microbiome/Peptidome-based Model for Non-invasive Detection of High-risk Gastroesophageal Varices in Compensated Cirrhosis (CHESS1901/APPHA1901)

Compensated Cirrhosis
Unknown
NCT05052892PrincipalInvestigator

A Novel Spleen-dedicated Stiffness Measured by FibroScan to Evaluate Cirrhotic Portal Hypertension (CHESS2105)

Portal Hypertension
Unknown

All 8 trials loaded